PMC · DOI:10.3389/fncel.2025.1650938·July 15, 2025
Editorial: Recent advances in mitochondrial dysfunction and therapeutics for neurodegeneration and aging
Monokesh K. Sen, Keagan Dunville, Nicole Miles, Michelle Newbery, Neville S. Ng, Lezanne Ooi
Abstract
Linked entities
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Genes25
Proteins23
Species3
Diseases28
CoA-related disordersPontocerebellar Hypoplasia Type 12Alzheimer's diseaseParkinson's diseasehypoxiacognitive and motor declinemotor deficitsTBIbrain injuryinflammationmitochondrial failureMitochondrialweight gainCoasy-linked disordersneurodegenerationneuroinflammationcalcium dysregulationhearing lossHuntington's diseasemitochondrial fragmentationmotor neuron diseaseneurodevelopmental disordersproteinopathiesbrain damageoptic atrophydopaminergic neuron lossnecroticlocomotor dysfunction
Mutations1
G2019S
Figures1
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsMitochondrial Function and Pathology · Neurogenesis and neuroplasticity mechanisms · Tryptophan and brain disorders